Literature DB >> 17309939

Use and misuse of the receiver operating characteristic curve in risk prediction.

Nancy R Cook1.   

Abstract

The c statistic, or area under the receiver operating characteristic (ROC) curve, achieved popularity in diagnostic testing, in which the test characteristics of sensitivity and specificity are relevant to discriminating diseased versus nondiseased patients. The c statistic, however, may not be optimal in assessing models that predict future risk or stratify individuals into risk categories. In this setting, calibration is as important to the accurate assessment of risk. For example, a biomarker with an odds ratio of 3 may have little effect on the c statistic, yet an increased level could shift estimated 10-year cardiovascular risk for an individual patient from 8% to 24%, which would lead to different treatment recommendations under current Adult Treatment Panel III guidelines. Accepted risk factors such as lipids, hypertension, and smoking have only marginal impact on the c statistic individually yet lead to more accurate reclassification of large proportions of patients into higher-risk or lower-risk categories. Perfectly calibrated models for complex disease can, in fact, only achieve values for the c statistic well below the theoretical maximum of 1. Use of the c statistic for model selection could thus naively eliminate established risk factors from cardiovascular risk prediction scores. As novel risk factors are discovered, sole reliance on the c statistic to evaluate their utility as risk predictors thus seems ill-advised.

Entities:  

Mesh:

Year:  2007        PMID: 17309939     DOI: 10.1161/CIRCULATIONAHA.106.672402

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  671 in total

1.  Controversies in cardioembolic stroke.

Authors:  Benjamin S Wessler; David M Kent
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-01

2.  Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models.

Authors:  Michael J Pencina; Ralph B D'Agostino; Olga V Demler
Journal:  Stat Med       Date:  2011-12-07       Impact factor: 2.373

Review 3.  Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.

Authors:  Alberto Ortiz; Ziad A Massy; Danilo Fliser; Bengt Lindholm; Andrzej Wiecek; Alberto Martínez-Castelao; Adrian Covic; David Goldsmith; Gültekin Süleymanlar; Gérard M London; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2011-11-01       Impact factor: 28.314

4.  Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors.

Authors:  Karen M Puopolo; David Draper; Soora Wi; Thomas B Newman; John Zupancic; Ellice Lieberman; Myesha Smith; Gabriel J Escobar
Journal:  Pediatrics       Date:  2011-10-24       Impact factor: 7.124

5.  Analytical and simulation methods for estimating the potential predictive ability of genetic profiling: a comparison of methods and results.

Authors:  Suman Kundu; Lennart C Karssen; A Cecile J W Janssens
Journal:  Eur J Hum Genet       Date:  2012-05-30       Impact factor: 4.246

6.  Screening for prostate cancer using multivariate mixed-effects models.

Authors:  Christopher H Morrell; Larry J Brant; Shan Sheng; E Jeffrey Metter
Journal:  J Appl Stat       Date:  2012-06-01       Impact factor: 1.404

7.  Genomic variation in natural populations of Drosophila melanogaster.

Authors:  Charles H Langley; Kristian Stevens; Charis Cardeno; Yuh Chwen G Lee; Daniel R Schrider; John E Pool; Sasha A Langley; Charlyn Suarez; Russell B Corbett-Detig; Bryan Kolaczkowski; Shu Fang; Phillip M Nista; Alisha K Holloway; Andrew D Kern; Colin N Dewey; Yun S Song; Matthew W Hahn; David J Begun
Journal:  Genetics       Date:  2012-06-05       Impact factor: 4.562

8.  Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients.

Authors:  Francesca Mallamaci; Giovanni Tripepi; Graziella D'Arrigo; Silvio Borrelli; Carlo Garofalo; Giovanna Stanzione; Michele Provenzano; Luca De Nicola; Giuseppe Conte; Roberto Minutolo; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-02       Impact factor: 8.237

9.  A clinical risk stratification tool for predicting treatment resistance in major depressive disorder.

Authors:  Roy H Perlis
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

10.  Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts.

Authors:  D S Cross; C A McCarty; E Hytopoulos; M Beggs; N Nolan; D S Harrington; T Hastie; R Tibshirani; R P Tracy; B M Psaty; R McClelland; P S Tsao; T Quertermous
Journal:  Curr Med Res Opin       Date:  2012-11       Impact factor: 2.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.